
Novo Nordisk layoffs: Pharma major notifies employees impacted by 9,000 job cuts amid restructuring drive
Denmark-based pharmaceuticals major, Novo Nordisk’s Chief Executive Officer (CEO) Mike Doustdar, on Friday, 31 October 2025, said that the company




